These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 12498928)
1. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids. Ihenetu K; Molleman A; Parsons ME; Whelan CJ Eur J Pharmacol; 2003 Jan; 458(1-2):207-15. PubMed ID: 12498928 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells. Ihenetu K; Molleman A; Parsons M; Whelan C Eur J Pharmacol; 2003 Mar; 464(2-3):207-15. PubMed ID: 12620515 [TBL] [Abstract][Full Text] [Related]
3. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed. Duncan M; Kendall DA; Ralevic V J Pharmacol Exp Ther; 2004 Oct; 311(1):411-9. PubMed ID: 15205450 [TBL] [Abstract][Full Text] [Related]
5. Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands. Smith SR; Terminelli C; Denhardt G Eur J Pharmacol; 2001 Aug; 425(1):73-83. PubMed ID: 11672577 [TBL] [Abstract][Full Text] [Related]
6. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. McMahon LR J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255 [TBL] [Abstract][Full Text] [Related]
7. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. Smith SR; Terminelli C; Denhardt G J Pharmacol Exp Ther; 2000 Apr; 293(1):136-50. PubMed ID: 10734163 [TBL] [Abstract][Full Text] [Related]
14. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor. Fride E; Foox A; Rosenberg E; Faigenboim M; Cohen V; Barda L; Blau H; Mechoulam R Eur J Pharmacol; 2003 Feb; 461(1):27-34. PubMed ID: 12568912 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Pertwee RG; Griffin G; Lainton JA; Huffman JW Eur J Pharmacol; 1995 Sep; 284(3):241-7. PubMed ID: 8666005 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Terranova JP; Michaud JC; Le Fur G; Soubrié P Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):576-9. PubMed ID: 8751088 [TBL] [Abstract][Full Text] [Related]
17. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor. Meschler JP; Kraichely DM; Wilken GH; Howlett AC Biochem Pharmacol; 2000 Nov; 60(9):1315-23. PubMed ID: 11008125 [TBL] [Abstract][Full Text] [Related]
18. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons. Liu Q; Bhat M; Bowen WD; Cheng J J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241 [TBL] [Abstract][Full Text] [Related]
19. Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors. Molderings GJ; Bönisch H; Hammermann R; Göthert M; Brüss M Neurochem Int; 2002 Feb; 40(2):157-67. PubMed ID: 11738482 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of SR141716A on G-protein activation in rat brain. Sim-Selley LJ; Brunk LK; Selley DE Eur J Pharmacol; 2001 Mar; 414(2-3):135-43. PubMed ID: 11239913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]